Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Diclofenac potassium 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diclofenac potassium |
Inferred relationship |
Some |
|
Diclofenac potassium 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diclofenac potassium |
Inferred relationship |
Some |
|
Product containing diclofenac potassium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diclofenac potassium |
Inferred relationship |
Some |
|
Diclofenac potassium 50 mg powder for oral solution sachet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diclofenac potassium |
Inferred relationship |
Some |
|
Diclofenac potassium 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diclofenac potassium |
Inferred relationship |
Some |
1 |
Diclofenac potassium 25 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Diclofenac potassium |
Inferred relationship |
Some |
1 |
Diclofenac potassium 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diclofenac potassium |
Inferred relationship |
Some |
1 |
Diclofenac potassium 50 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Diclofenac potassium |
Inferred relationship |
Some |
1 |
Diclofenac potassium 50 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Diclofenac potassium |
Inferred relationship |
Some |
1 |
Diclofenac potassium 25 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Diclofenac potassium |
Inferred relationship |
Some |
1 |
Diclofenac potassium 50 mg powder for oral solution sachet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Diclofenac potassium |
Inferred relationship |
Some |
1 |
Diclofenac potassium 50 mg powder for oral solution sachet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Diclofenac potassium |
Inferred relationship |
Some |
1 |
Product containing precisely chlorzoxazone 500 milligram and diclofenac potassium 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Diclofenac potassium |
Inferred relationship |
Some |
1 |
Product containing precisely chlorzoxazone 500 milligram and diclofenac potassium 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Diclofenac potassium |
Inferred relationship |
Some |
1 |
Diclofenac potassium 50 mg and paracetamol 325 mg and serrapeptase 10 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Diclofenac potassium |
Inferred relationship |
Some |
2 |
Diclofenac potassium 50 mg and paracetamol 325 mg and serrapeptase 10 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Diclofenac potassium |
Inferred relationship |
Some |
2 |
Product containing precisely diclofenac potassium 50 milligram and paracetamol 325 milligram and serrapeptase 15 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Diclofenac potassium |
Inferred relationship |
Some |
2 |
Product containing precisely diclofenac potassium 50 milligram and paracetamol 325 milligram and serrapeptase 15 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Diclofenac potassium |
Inferred relationship |
Some |
2 |